No Appeal of LDT/FDA Lawsuit

No Appeal of LDT/FDA Lawsuit

The FDA had until May 30 to appeal U.S. District Court Judge Sean D. Jordan's decision to vacate the agency's Final Rule seeking to regulate laboratory developed tests (LDTs). The federal government declined to appeal the judge's decision meaning the Texas District Court's decision to vacate, in its entirety, the FDA's attempt to regulate LDTs as medical devices stands.

Read ACLA’s full lawsuit.

Read the Final Judgment.

 

CMS Adopts Final Rule Phasing Out Fax and Mail for Health Care Claims Attachments

CMS Adopts Final Rule Phasing Out Fax and Mail for Health Care Claims Attachments

The Centers for Medicare & Medicaid Services (CMS) issued a final rule on national standards for electronic claims attachments and signatures,...

Read More
CMS Clarifies CLIA Certification Requirements for Remote Cytology

CMS Clarifies CLIA Certification Requirements for Remote Cytology

The Centers for Medicare & Medicaid Services (CMS) recently clarified Clinical Laboratory Improvement Act (CLIA) certification requirements for...

Read More
TELCOR Promotions - April 2026

TELCOR Promotions - April 2026

Lincoln, NE – April 2026 TELCOR is proud to announce the promotion ofJoni Fitzgerald to Senior Revenue Cycle Supervisor, Natalie Helkenn to RCS...

Read More